🇺🇸 FDA
Pipeline program

Immune Globulin Intravenous (Human), 10% Solution

161003

Phase 3 mab terminated

Quick answer

Immune Globulin Intravenous (Human), 10% Solution for Alzheimer´s Disease is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Alzheimer´s Disease
Phase
Phase 3
Modality
mab
Status
terminated

Clinical trials